Other at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept jazz:DeferredOtherIncomeTaxExpenseBenefitIncreaseDecreaseInTaxRate.
The official record: Jazz Pharmaceuticals’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's other.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's other?
- Jazz Pharmaceuticals (JAZZ) reported other of $0 in Q4 2025.
- How has Jazz Pharmaceuticals's other changed year-over-year?
- Jazz Pharmaceuticals's other increased by 100.0% year-over-year, from -$4.25K to $0.
- What is the long-term trend for Jazz Pharmaceuticals's other?
- Over 4 years (2021 to 2025), Jazz Pharmaceuticals's other has grown at a -100.0% compound annual growth rate (CAGR), from $5K to $0.
- What does other mean?
- Other miscellaneous adjustments to deferred tax expenses.
- How do you interpret other?
- Fluctuations here may signal changes in tax accounting estimates or minor adjustments to valuation allowances.
- How does other compare across companies?
- Often found in the tax reconciliation notes of large multinational corporations.